SEC Form 4 · accession 0001209191-15-004039
Dicerna Pharmaceuticals Inc · DRNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Theodore Ashburn
Officer — See Remarks
Period of report
Jan 9, 2015
Accepted (ET)
Jan 13, 2015 · 8:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001399529
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $18.50 | Jan 9, 2015 | A | 3,333 | A | — | Jan 9, 2025 | Common Stock | 3,333 | 3,333 | D |
Explanation of responses
- F1The option vests in 48 monthly installments over the four-year period with a vesting start date of January 9, 2015, subject in each case to the reporting person's continued employment with the issuer through the applicable vesting date.
Remarks
Senior Vice President, Product Strategy and Operations